Accurate prediction of disease-risk factors from volumetric medical scans by a deep vision model pre-trained with 2D scans
- PMID: 39354052
- DOI: 10.1038/s41551-024-01257-9
Accurate prediction of disease-risk factors from volumetric medical scans by a deep vision model pre-trained with 2D scans
Abstract
The application of machine learning to tasks involving volumetric biomedical imaging is constrained by the limited availability of annotated datasets of three-dimensional (3D) scans for model training. Here we report a deep-learning model pre-trained on 2D scans (for which annotated data are relatively abundant) that accurately predicts disease-risk factors from 3D medical-scan modalities. The model, which we named SLIViT (for 'slice integration by vision transformer'), preprocesses a given volumetric scan into 2D images, extracts their feature map and integrates it into a single prediction. We evaluated the model in eight different learning tasks, including classification and regression for six datasets involving four volumetric imaging modalities (computed tomography, magnetic resonance imaging, optical coherence tomography and ultrasound). SLIViT consistently outperformed domain-specific state-of-the-art models and was typically as accurate as clinical specialists who had spent considerable time manually annotating the analysed scans. Automating diagnosis tasks involving volumetric scans may save valuable clinician hours, reduce data acquisition costs and duration, and help expedite medical research and clinical applications.
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: E.H. has an affiliation with Optum. S.R.S. has affiliations with Abbvie/Allergan, Alexion, Amgen, Apellis, ARVO, Astellas, Bayer, Biogen, Boerhinger Ingelheim, Carl Zeiss Meditec, Centervue, Character, Eyepoint, Heidelberg, iCare, IvericBio, Jannsen, Macula Society, Nanoscope, Nidek, NotalVision, Novartis, Optos, OTx, Pfizer, Regeneron, Roche, Samsung Bioepis and Topcon. The other authors declare no competing interests.
Update of
-
SLIViT: a general AI framework for clinical-feature diagnosis from limited 3D biomedical-imaging data.Res Sq [Preprint]. 2023 Nov 21:rs.3.rs-3044914. doi: 10.21203/rs.3.rs-3044914/v2. Res Sq. 2023. Update in: Nat Biomed Eng. 2025 Apr;9(4):507-520. doi: 10.1038/s41551-024-01257-9. PMID: 38045283 Free PMC article. Updated. Preprint.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources